Surfactant deficiency in adults

Clinical Pulmonary Medicine

Volumn 9, Issue 1, 2002, Pages 39-45

  Hite, Robert Duncan ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ARDS; Inflammation; Obstructive lung disease; Replacement therapy; Surfactant

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; LUCINACTANT; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; LUSUPULTIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG COST; HUMAN; LIPID COMPOSITION; LUNG ALVEOLUS SURFACE TENSION; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; MUCOCILIARY CLEARANCE; NEONATAL RESPIRATORY DISTRESS SYNDROME; PATHOPHYSIOLOGY; PREMATURITY; PROTEIN ANALYSIS; RESPIRATORY TRACT INFECTION; SURFACTANT DEFICIENCY; SURVIVAL;

EID: 0036144843     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-200201000-00006     Document Type: Article

References (32)

1. Pulmonary surfactant: Functions and molecular composition
2. Molecular and cellular processing of lung surfactant
3. Regulatory mechanisms of surfactant secretion
4. The surface-associated surfactant reservoir in the alveolar lining
5. The role of lipids in pulmonary surfactant
6. Interfacial properties of surfactant proteins
7. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice
8. Neue auffassungen uber einen grundbegriff der atemmechardk: Die retraktionskraft der lunge, abhangig von der oberflachenspannung in den alveolen
9. The alveolar surface network: A new anatomy and its physiological significance
10. The stability of peripheral airways
11. Pulmonary surfactant maintains patency of conducting airways in the rat
12. Role of the physicochemical properties of mucus in the protection of the respiratory epithelium
13. Immunomodulatory functions of surfactant
14. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis
15. Surface properties in relation to atelectasis and hyaline membrane disease
16. Surfactant abnormalities in babies dying from sudden infant death syndrome
17. Surfactant chemical composition and biophysical activity, in acute respiratory distress syndrome
18. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge
19. The spectrum of surfactant dysfunction in an endobronchial challenge model of asthma
20. Inhibition of pulmonary surfactant function in smokers
21. Pulmonary surfactant in cystic fibrosis
22. Surfactant proteins A and D: Disease markers
23. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in pre-term neonates with respiratory distress syndrome: Final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials
24. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure
25. Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome
26. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome
27. Bovine surfactant therapy for patients with acute respiratory distress syndrome
28. 4-surfactant) for acute respiratory distress syndrome
29. Treatment of ARDS with rSP-C surfactant
30. A pilot study of surfactant inhalation in the treatment of asthmatic attack
31. Effects of aerosolized surfactant in patients with stable chronic bronchitis: A prospective randomized controlled trial